Cupps Capital Management’s Celgene Corp CELG Stock Holding History

Cupps Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$11K	Sell	112 -12,759	-99%	-$1.38M	﹤0.01%	157
2016 Q2	$1.27M	Buy	+12,871	New	+$1.33M	0.33%	109
2014 Q2	–	Sell	-1,034	Closed	-$72K	–	274
2014 Q1	$72K	Sell	1,034 -34,706	-97%	-$2.75M	0.01%	168
2013 Q4	$3.02M	Buy	35,740 +9,248	+35%	+$732K	0.21%	105
2013 Q3	$2.04M	Sell	26,492 -12,788	-33%	-$896K	0.13%	112
2013 Q2	$2.3M	Buy	+39,280	New	+$2.36M	0.18%	100

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cupps Capital Management's CELG Position: Q3 2016 in Review

Cupps Capital Management reduced its Celgene Corp (CELG) stake by 99% in Q3 2016, selling an estimated $1.38M and leaving 112 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #157.

Cupps Capital Management first reported a position in CELG in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.02M in Q4 2013. 1,278 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

Cupps Capital Management held 112 shares of Celgene Corp worth $11K as of Q3 2016.
Cupps Capital Management sold 12,759 Celgene Corp shares in Q3 2016, an estimated $1.38M.
Celgene Corp made up ﹤0.01% of Cupps Capital Management's portfolio in Q3 2016, its #157 holding.
Cupps Capital Management first reported a position in Celgene Corp in Q2 2013 and has held it in 6 quarters since.
Cupps Capital Management's Celgene Corp position peaked at $3.02M in Q4 2013.
1,278 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.